Company news

GSK plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

GSK gives update on RSV maternal vaccine candidate

February 18, 2022

Benlysta approved in China for Lupus Nephritis

February 10, 2022

Publication of full year 2021 results: Replacement

February 7, 2022

Publication of full year 2021 results

February 7, 2022

GSK announces settlement between ViiV and Gilead

February 2, 2022

FDA approves ViiV Healthcare's sNDA for Cabenuva

February 1, 2022

Tony Wood appointed CSO Designate, GSK

January 19, 2022

Update - GSK Consumer Healthcare

January 17, 2022

US Govt buys additional 600,000 sotrovimab doses

January 11, 2022

ViiV Healthcare announces FDA approval of Apretude

December 21, 2021

Consumer Healthcare Chair Designate appointed

December 20, 2021

Xevudy approved in Europe to treat COVID-19

December 17, 2021

GSK/Sanofi COVID-19 vaccine booster & Ph3 update

December 15, 2021

Medicago/GSK COVID-19 vaccine positive Ph3 data

December 7, 2021

Sotrovimab retains its activity vs Omicron variant

December 7, 2021

GSK publishes provisional 2022 dividend dates

November 24, 2021

Nucala approved in Europe for more indications

November 17, 2021

Phase III IM administration data for sotrovimab

November 12, 2021

GSK shares positive Phase III data for daprodustat

November 5, 2021

SK bio & GSK start Ph3 Covid-19 vaccine trial

August 31, 2021

Director/PDMR Shareholding - amendment

August 13, 2021

CEO Designate of new Consumer Healthcare company

July 22, 2021

GSK announces daprodustat phase 3 headline results

July 16, 2021

GSK and Alector collaboration in immuno-neurology

July 2, 2021

Elliott Advisors (UK) letter to GSK

July 2, 2021

GSK to deliver step-change in growth & performance

June 23, 2021

ViiV/Halozyme sign exclusive licensing agreement

June 22, 2021

GSK and iTeos announce collaboration for EOS-448

June 14, 2021

GSK recommend ADR holders reject mini-tender offer

June 4, 2021

Sanofi and GSK initiate new Phase 3 clinical study

May 27, 2021

GSK/Vir Sotrovimab FDA Emergency Use Authorization

May 27, 2021

GSK/VIR sotrovimab receives positive EMA opinion

May 21, 2021

Medicago/GSK COVID-19 Vaccine Positive Ph2 Results

May 18, 2021

Sanofi/GSK COVID-19 Vaccine Positive Ph2 Results

May 17, 2021

EMTN Prospectus

May 11, 2021

← Newer news releases

Calls

The 5 newest of 27 calls. Every call is listed under its year.

Decks

The 5 newest of 182 decks. Every deck is listed under its year.